About KSQ Therapeutics
At KSQ Therapeutics, we seek to understand the role of every human gene in each disease, each tissue, and each cell that we study. This comprehensive approach has resulted in a massive, experimentally derived dataset that we have found to be remarkably predictive of past successes and failures in oncology and immuno-oncology product development. Utilizing this approach, we also identified a number of opportunities for the development of new medicines. As a result, we have aggressively invested in these distinct, highly validated pathways for new drug development with the expectation that the medicines we create may become the next breakthrough products for patients.
Founded in late 2015, KSQ is a preclinical-stage biotech in Kendall Square that has rapidly advanced the field of CRISPR-enabled functional genomics, from in vitro cell autonomous screens to more complex genome-scale screens of immune cells in vivo. The company has expanded the scope of its technology to include multiple cell types and to unlock areas beyond oncology. KSQ is led by a team of accomplished industry experts in drug discovery and development. We maintain a lively and inquisitive environment in the heart of the vibrant Kendall Square neighborhood.
We seek a motivated and team-oriented individual who will be a key contributor to the overall success of KSQs in vivo pharmacology department. The successful candidate will contribute hands-on technical expertise for all aspects of in vivo pharmacology including tumor xenograft, MTD, and PK/PD studies to help evaluate the pharmacology of novel therapeutic agents.
RequirementsRequirements & Qualifications:
Requires a B.S. with 3-5+ years of experience in pharmacology in an industry setting or MSc with 1-3+ years of drug discovery experience in the biotechnology or pharmaceutical industry with the following:
The successful candidate will: